Kathleen Gallagher is chief executive of Atrium, which is developing siRNA therapies for genetic cardiomyopathies. As Novartis completed its $12 billion takeover of Avidity, a new cardiology-focused ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Atrium has once again proven itself as a true innovator by fulfilling previously unmet clinical needs in a way that benefits both the clinician and patient. By including pre-packaged sterile water to ...

Atrium water seal chest drains set the standard for ease of use, speed of set up, and high performance vacuum control. When it comes to monitoring small changes in patient drainage, fast, accurate ...

Atrium Health Wake Forest Baptist announced Wednesday it has expanded its Kernersville presence with the opening of an orthopaedics and sports medicine facility and a podiatry clinic. Both are located ...